0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gabapentin Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-16D300
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gabapentin Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Gabapentin Market Research Report 2024

Code: QYRE-Auto-16D300
Report
February 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gabapentin Market Size

The global Gabapentin market was valued at US$ 1542 million in 2023 and is anticipated to reach US$ 1749.7 million by 2030, witnessing a CAGR of 1.8% during the forecast period 2024-2030.

Gabapentin Market

Gabapentin Market

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.
North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.
In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.
This report aims to provide a comprehensive presentation of the global market for Gabapentin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gabapentin.

Report Scope

The Gabapentin market size, estimations, and forecasts are provided in terms of sales volume (M Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gabapentin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gabapentin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gabapentin Market Report

Report Metric Details
Report Name Gabapentin Market
Accounted market size in 2023 US$ 1542 million
Forecasted market size in 2030 US$ 1749.7 million
CAGR 1.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Capsule
  • Tablet
Segment by Application
  • Epilepsy
  • Neuropathic Pain
  • Restless Legs Syndrome
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Assertio Therapeutics, TEVA, Mylan, Arbor Pharma, Novartis, Apotex, Sun Pharmaceutical, Aurobindo Pharma, Intas, Amneal, Marksans Pharma, Glenmark, Alkem, Jiangsu Enhua, Jiangsu Hengrui, Sailike
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gabapentin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gabapentin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Gabapentin Market growing?

Ans: The Gabapentin Market witnessing a CAGR of 1.8% during the forecast period 2024-2030.

What is the Gabapentin Market size in 2030?

Ans: The Gabapentin Market size in 2030 will be US$ 1749.7 million.

What is the market share of major companies in Gabapentin Market?

Ans: Global top four manufacturers hold a share about 20%.

What is the Gabapentin Market share by type?

Ans: In terms of product, Capsule is the largest segment, with a share about 55%.

Who are the main players in the Gabapentin Market report?

Ans: The main players in the Gabapentin Market are Pfizer, Assertio Therapeutics, TEVA, Mylan, Arbor Pharma, Novartis, Apotex, Sun Pharmaceutical, Aurobindo Pharma, Intas, Amneal, Marksans Pharma, Glenmark, Alkem, Jiangsu Enhua, Jiangsu Hengrui, Sailike

What are the Application segmentation covered in the Gabapentin Market report?

Ans: The Applications covered in the Gabapentin Market report are Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others

What are the Type segmentation covered in the Gabapentin Market report?

Ans: The Types covered in the Gabapentin Market report are Capsule, Tablet

1 Gabapentin Market Overview
1.1 Product Overview and Scope of Gabapentin
1.2 Gabapentin Segment by Type
1.2.1 Global Gabapentin Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Segment by Application
1.3.1 Global Gabapentin Market Value by Application: (2024-2030)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Global Gabapentin Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Revenue 2019-2030
1.4.2 Global Gabapentin Sales 2019-2030
1.4.3 Global Gabapentin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gabapentin Market Competition by Manufacturers
2.1 Global Gabapentin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gabapentin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gabapentin Average Price by Manufacturers (2019-2024)
2.4 Global Gabapentin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gabapentin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabapentin, Product Type & Application
2.7 Gabapentin Market Competitive Situation and Trends
2.7.1 Gabapentin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gabapentin Players Market Share by Revenue
2.7.3 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gabapentin Retrospective Market Scenario by Region
3.1 Global Gabapentin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gabapentin Global Gabapentin Sales by Region: 2019-2030
3.2.1 Global Gabapentin Sales by Region: 2019-2024
3.2.2 Global Gabapentin Sales by Region: 2025-2030
3.3 Global Gabapentin Global Gabapentin Revenue by Region: 2019-2030
3.3.1 Global Gabapentin Revenue by Region: 2019-2024
3.3.2 Global Gabapentin Revenue by Region: 2025-2030
3.4 North America Gabapentin Market Facts & Figures by Country
3.4.1 North America Gabapentin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gabapentin Sales by Country (2019-2030)
3.4.3 North America Gabapentin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gabapentin Market Facts & Figures by Country
3.5.1 Europe Gabapentin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gabapentin Sales by Country (2019-2030)
3.5.3 Europe Gabapentin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabapentin Market Facts & Figures by Country
3.6.1 Asia Pacific Gabapentin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gabapentin Sales by Country (2019-2030)
3.6.3 Asia Pacific Gabapentin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gabapentin Market Facts & Figures by Country
3.7.1 Latin America Gabapentin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gabapentin Sales by Country (2019-2030)
3.7.3 Latin America Gabapentin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabapentin Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabapentin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gabapentin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gabapentin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Gabapentin Sales by Type (2019-2030)
4.1.1 Global Gabapentin Sales by Type (2019-2024)
4.1.2 Global Gabapentin Sales by Type (2025-2030)
4.1.3 Global Gabapentin Sales Market Share by Type (2019-2030)
4.2 Global Gabapentin Revenue by Type (2019-2030)
4.2.1 Global Gabapentin Revenue by Type (2019-2024)
4.2.2 Global Gabapentin Revenue by Type (2025-2030)
4.2.3 Global Gabapentin Revenue Market Share by Type (2019-2030)
4.3 Global Gabapentin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gabapentin Sales by Application (2019-2030)
5.1.1 Global Gabapentin Sales by Application (2019-2024)
5.1.2 Global Gabapentin Sales by Application (2025-2030)
5.1.3 Global Gabapentin Sales Market Share by Application (2019-2030)
5.2 Global Gabapentin Revenue by Application (2019-2030)
5.2.1 Global Gabapentin Revenue by Application (2019-2024)
5.2.2 Global Gabapentin Revenue by Application (2025-2030)
5.2.3 Global Gabapentin Revenue Market Share by Application (2019-2030)
5.3 Global Gabapentin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Gabapentin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Assertio Therapeutics
6.2.1 Assertio Therapeutics Corporation Information
6.2.2 Assertio Therapeutics Description and Business Overview
6.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Assertio Therapeutics Gabapentin Product Portfolio
6.2.5 Assertio Therapeutics Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TEVA Gabapentin Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Gabapentin Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Arbor Pharma
6.5.1 Arbor Pharma Corporation Information
6.5.2 Arbor Pharma Description and Business Overview
6.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Arbor Pharma Gabapentin Product Portfolio
6.5.5 Arbor Pharma Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Gabapentin Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Gabapentin Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceutical Gabapentin Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aurobindo Pharma Gabapentin Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Intas
6.10.1 Intas Corporation Information
6.10.2 Intas Description and Business Overview
6.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Intas Gabapentin Product Portfolio
6.10.5 Intas Recent Developments/Updates
6.11 Amneal
6.11.1 Amneal Corporation Information
6.11.2 Amneal Gabapentin Description and Business Overview
6.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Amneal Gabapentin Product Portfolio
6.11.5 Amneal Recent Developments/Updates
6.12 Marksans Pharma
6.12.1 Marksans Pharma Corporation Information
6.12.2 Marksans Pharma Gabapentin Description and Business Overview
6.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Marksans Pharma Gabapentin Product Portfolio
6.12.5 Marksans Pharma Recent Developments/Updates
6.13 Glenmark
6.13.1 Glenmark Corporation Information
6.13.2 Glenmark Gabapentin Description and Business Overview
6.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Glenmark Gabapentin Product Portfolio
6.13.5 Glenmark Recent Developments/Updates
6.14 Alkem
6.14.1 Alkem Corporation Information
6.14.2 Alkem Gabapentin Description and Business Overview
6.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Alkem Gabapentin Product Portfolio
6.14.5 Alkem Recent Developments/Updates
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Corporation Information
6.15.2 Jiangsu Enhua Gabapentin Description and Business Overview
6.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiangsu Enhua Gabapentin Product Portfolio
6.15.5 Jiangsu Enhua Recent Developments/Updates
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Corporation Information
6.16.2 Jiangsu Hengrui Gabapentin Description and Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jiangsu Hengrui Gabapentin Product Portfolio
6.16.5 Jiangsu Hengrui Recent Developments/Updates
6.17 Sailike
6.17.1 Sailike Corporation Information
6.17.2 Sailike Gabapentin Description and Business Overview
6.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sailike Gabapentin Product Portfolio
6.17.5 Sailike Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabapentin Industry Chain Analysis
7.2 Gabapentin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabapentin Production Mode & Process
7.4 Gabapentin Sales and Marketing
7.4.1 Gabapentin Sales Channels
7.4.2 Gabapentin Distributors
7.5 Gabapentin Customers
8 Gabapentin Market Dynamics
8.1 Gabapentin Industry Trends
8.2 Gabapentin Market Drivers
8.3 Gabapentin Market Challenges
8.4 Gabapentin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Gabapentin Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Gabapentin Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Gabapentin Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Gabapentin Sales (M Unit) of Key Manufacturers (2019-2024)
    Table 5. Global Gabapentin Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Gabapentin Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Gabapentin Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Gabapentin Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Gabapentin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Gabapentin, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Gabapentin, Product Type & Application
    Table 12. Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Gabapentin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Gabapentin Sales by Region (2019-2024) & (M Unit)
    Table 18. Global Gabapentin Sales Market Share by Region (2019-2024)
    Table 19. Global Gabapentin Sales by Region (2025-2030) & (M Unit)
    Table 20. Global Gabapentin Sales Market Share by Region (2025-2030)
    Table 21. Global Gabapentin Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Gabapentin Revenue Market Share by Region (2019-2024)
    Table 23. Global Gabapentin Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Gabapentin Revenue Market Share by Region (2025-2030)
    Table 25. North America Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Gabapentin Sales by Country (2019-2024) & (M Unit)
    Table 27. North America Gabapentin Sales by Country (2025-2030) & (M Unit)
    Table 28. North America Gabapentin Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Gabapentin Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Gabapentin Sales by Country (2019-2024) & (M Unit)
    Table 32. Europe Gabapentin Sales by Country (2025-2030) & (M Unit)
    Table 33. Europe Gabapentin Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Gabapentin Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Gabapentin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Gabapentin Sales by Region (2019-2024) & (M Unit)
    Table 37. Asia Pacific Gabapentin Sales by Region (2025-2030) & (M Unit)
    Table 38. Asia Pacific Gabapentin Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Gabapentin Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Gabapentin Sales by Country (2019-2024) & (M Unit)
    Table 42. Latin America Gabapentin Sales by Country (2025-2030) & (M Unit)
    Table 43. Latin America Gabapentin Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Gabapentin Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Gabapentin Sales by Country (2019-2024) & (M Unit)
    Table 47. Middle East & Africa Gabapentin Sales by Country (2025-2030) & (M Unit)
    Table 48. Middle East & Africa Gabapentin Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Gabapentin Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Gabapentin Sales (M Unit) by Type (2019-2024)
    Table 51. Global Gabapentin Sales (M Unit) by Type (2025-2030)
    Table 52. Global Gabapentin Sales Market Share by Type (2019-2024)
    Table 53. Global Gabapentin Sales Market Share by Type (2025-2030)
    Table 54. Global Gabapentin Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Gabapentin Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Gabapentin Revenue Market Share by Type (2019-2024)
    Table 57. Global Gabapentin Revenue Market Share by Type (2025-2030)
    Table 58. Global Gabapentin Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Gabapentin Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Gabapentin Sales (M Unit) by Application (2019-2024)
    Table 61. Global Gabapentin Sales (M Unit) by Application (2025-2030)
    Table 62. Global Gabapentin Sales Market Share by Application (2019-2024)
    Table 63. Global Gabapentin Sales Market Share by Application (2025-2030)
    Table 64. Global Gabapentin Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Gabapentin Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Gabapentin Revenue Market Share by Application (2019-2024)
    Table 67. Global Gabapentin Revenue Market Share by Application (2025-2030)
    Table 68. Global Gabapentin Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Gabapentin Price (USD/Unit) by Application (2025-2030)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Pfizer Gabapentin Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. Assertio Therapeutics Corporation Information
    Table 76. Assertio Therapeutics Description and Business Overview
    Table 77. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Assertio Therapeutics Gabapentin Product
    Table 79. Assertio Therapeutics Recent Developments/Updates
    Table 80. TEVA Corporation Information
    Table 81. TEVA Description and Business Overview
    Table 82. TEVA Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. TEVA Gabapentin Product
    Table 84. TEVA Recent Developments/Updates
    Table 85. Mylan Corporation Information
    Table 86. Mylan Description and Business Overview
    Table 87. Mylan Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Mylan Gabapentin Product
    Table 89. Mylan Recent Developments/Updates
    Table 90. Arbor Pharma Corporation Information
    Table 91. Arbor Pharma Description and Business Overview
    Table 92. Arbor Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Arbor Pharma Gabapentin Product
    Table 94. Arbor Pharma Recent Developments/Updates
    Table 95. Novartis Corporation Information
    Table 96. Novartis Description and Business Overview
    Table 97. Novartis Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Novartis Gabapentin Product
    Table 99. Novartis Recent Developments/Updates
    Table 100. Apotex Corporation Information
    Table 101. Apotex Description and Business Overview
    Table 102. Apotex Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Apotex Gabapentin Product
    Table 104. Apotex Recent Developments/Updates
    Table 105. Sun Pharmaceutical Corporation Information
    Table 106. Sun Pharmaceutical Description and Business Overview
    Table 107. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Sun Pharmaceutical Gabapentin Product
    Table 109. Sun Pharmaceutical Recent Developments/Updates
    Table 110. Aurobindo Pharma Corporation Information
    Table 111. Aurobindo Pharma Description and Business Overview
    Table 112. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Aurobindo Pharma Gabapentin Product
    Table 114. Aurobindo Pharma Recent Developments/Updates
    Table 115. Intas Corporation Information
    Table 116. Intas Description and Business Overview
    Table 117. Intas Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Intas Gabapentin Product
    Table 119. Intas Recent Developments/Updates
    Table 120. Amneal Corporation Information
    Table 121. Amneal Description and Business Overview
    Table 122. Amneal Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Amneal Gabapentin Product
    Table 124. Amneal Recent Developments/Updates
    Table 125. Marksans Pharma Corporation Information
    Table 126. Marksans Pharma Description and Business Overview
    Table 127. Marksans Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. Marksans Pharma Gabapentin Product
    Table 129. Marksans Pharma Recent Developments/Updates
    Table 130. Glenmark Corporation Information
    Table 131. Glenmark Description and Business Overview
    Table 132. Glenmark Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 133. Glenmark Gabapentin Product
    Table 134. Glenmark Recent Developments/Updates
    Table 135. Alkem Corporation Information
    Table 136. Alkem Description and Business Overview
    Table 137. Alkem Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 138. Alkem Gabapentin Product
    Table 139. Alkem Recent Developments/Updates
    Table 140. Jiangsu Enhua Corporation Information
    Table 141. Jiangsu Enhua Description and Business Overview
    Table 142. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 143. Jiangsu Enhua Gabapentin Product
    Table 144. Jiangsu Enhua Recent Developments/Updates
    Table 145. Jiangsu Hengrui Corporation Information
    Table 146. Jiangsu Hengrui Description and Business Overview
    Table 147. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 148. Jiangsu Hengrui Gabapentin Product
    Table 149. Jiangsu Hengrui Recent Developments/Updates
    Table 150. Sailike Corporation Information
    Table 151. Sailike Description and Business Overview
    Table 152. Sailike Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 153. Sailike Gabapentin Product
    Table 154. Sailike Recent Developments/Updates
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Gabapentin Distributors List
    Table 158. Gabapentin Customers List
    Table 159. Gabapentin Market Trends
    Table 160. Gabapentin Market Drivers
    Table 161. Gabapentin Market Challenges
    Table 162. Gabapentin Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Gabapentin
    Figure 2. Global Gabapentin Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Gabapentin Market Share by Type in 2023 & 2030
    Figure 4. Capsule Product Picture
    Figure 5. Tablet Product Picture
    Figure 6. Global Gabapentin Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Gabapentin Market Share by Application in 2023 & 2030
    Figure 8. Epilepsy
    Figure 9. Neuropathic Pain
    Figure 10. Restless Legs Syndrome
    Figure 11. Others
    Figure 12. Global Gabapentin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Gabapentin Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Gabapentin Sales (2019-2030) & (M Unit)
    Figure 15. Global Gabapentin Average Price (USD/Unit) & (2019-2030)
    Figure 16. Gabapentin Report Years Considered
    Figure 17. Gabapentin Sales Share by Manufacturers in 2023
    Figure 18. Global Gabapentin Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Gabapentin Players: Market Share by Revenue in 2023
    Figure 20. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Gabapentin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Gabapentin Sales Market Share by Country (2019-2030)
    Figure 23. North America Gabapentin Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Gabapentin Sales Market Share by Country (2019-2030)
    Figure 27. Europe Gabapentin Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Gabapentin Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Gabapentin Revenue Market Share by Region (2019-2030)
    Figure 35. China Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Gabapentin Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Gabapentin Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Gabapentin Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Gabapentin Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Gabapentin by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Gabapentin by Type (2019-2030)
    Figure 57. Global Gabapentin Price (USD/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Gabapentin by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Gabapentin by Application (2019-2030)
    Figure 60. Global Gabapentin Price (USD/Unit) by Application (2019-2030)
    Figure 61. Gabapentin Value Chain
    Figure 62. Gabapentin Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS